BRINFORT

Welcome to the Brand page for “BRINFORT”, which is offered here for Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, dermatologic disorders, hemostatic agents, metabolic diseases, anti-viral diseases, oncologic diseases, and respiratory diseases;.

Its status is currently believed to be active. Its class is unavailable. “BRINFORT” is believed to be currently owned by “Johnson & Johnson”.